For the majority of asthma patients — mild through moderate-severe — SMART therapy provides excellent control and no biologic is required. Biologic therapy is reserved for truly severe, uncontrolled asthma (GINA Step 5) that continues despite optimal SMART. At Pulmovista Clinics, Dr. Dixit Kumar Thakur conducts a structured biomarker evaluation to determine biologic candidacy.